EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Gephyrin Neurological Autoimmunity

Maria Chiara Pantuliano iD, Friederike A Arlt iD, Naomi Arenson, Irena Dujmovic Basuroski, Divyanshu Dubey iD, Connie E Lesnick, John R Mills, Sean J Pittock iD, Anastasia Zekeridou iD, Michael A Lane, Andrew McKeon iD

Annals of Neurology · 2026

DOI: 10.1002/ana.78278 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Neurology, 2026. Verfasst von Maria Chiara Pantuliano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Membrane Proteins, Carrier Proteins, Autoimmune Diseases of the Nervous System, Immunoglobulin G. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gephyrin is a postsynaptic scaffold protein essential for inhibitory neurotransmission. Gephyrin‐immunoglobulin G (IgG) was reported, decades ago, in a single case of paraneoplastic stiff‐person‐like syndrome, but its broader clinical relevance remains unknown. While investigating unclassified synaptic IgGs mimicking amphiphysin‐IgG, we identified gephyrin‐IgG in 3 patients using human protein microarray. Gephyrin specificity was confirmed using confocal tissue‐based immunofluorescence assay, cell‐based assay, and Western blot. The 3 patients, all female, had: encephalitis (2) and myeloneuropathy and breast cancer (1). All had inflammatory cerebrospinal fluid and abnormal magnetic resonance imaging, and improved following immunotherapy. Gephyrin‐IgG is associated with a treatable autoimmune neurological disease, sometimes paraneoplastic. ANN NEUROL 2026;100:781–787

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsCarrier ProteinsAutoimmune Diseases of the Nervous SystemImmunoglobulin GAutoimmunityEncephalitisHumansFemaleMiddle AgedAdultBreast NeoplasmsAutoantibodies

Substanzen

gephyrinMembrane ProteinsCarrier ProteinsImmunoglobulin GAutoantibodies

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Department of Medicine and Surgery, Unit of Neurology, Neurophysiology, Neurobiology and Psychiatry, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Department of Neurology, Central Peninsula Hospital, Soldotna, AK.
  • Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC.
  • Department of Neurology, Mayo Clinic, Rochester, MN.

ORCID-Profile: Maria Chiara Pantuliano, Friederike A Arlt, Divyanshu Dubey, Sean J Pittock, Anastasia Zekeridou, Andrew McKeon

Förderung

  • NINDS NIH HHS

Zitieren

APA

Pantuliano, M. C., Arlt, F. A., Arenson, N., Basuroski, I. D., Dubey, D., Lesnick, C. E., Mills, J. R., Pittock, S. J., Zekeridou, A., Lane, M. A., & McKeon, A. (2026). Gephyrin Neurological Autoimmunity. Annals of Neurology. https://doi.org/10.1002/ana.78278

Vancouver

Pantuliano MC, Arlt FA, Arenson N, Basuroski ID, Dubey D, Lesnick CE, et al. Gephyrin Neurological Autoimmunity. Annals of Neurology. 2026. doi:10.1002/ana.78278

BibTeX
@article{Pantuliano2026,
  author = {Pantuliano, Maria Chiara and Arlt, Friederike A and Arenson, Naomi and Basuroski, Irena Dujmovic and Dubey, Divyanshu and Lesnick, Connie E and Mills, John R and Pittock, Sean J and Zekeridou, Anastasia and Lane, Michael A and McKeon, Andrew},
  title = {Gephyrin Neurological Autoimmunity},
  journal = {Annals of Neurology},
  year = {2026},
  doi = {10.1002/ana.78278}
}
Kostenlos starten →